3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
4
Head and Neck Neoplasms
2
Virus Diseases
1
Tumor Virus Infections
1
Recurrence
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers
1
Laryngeal Diseases
1
Hypoxia
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Cisplatin
56
Radiotherapy
34
Radiotherapy, Intensity-Modulated
28
Magnetic Resonance Spectroscopy
24
Radiation
20
Carboplatin
19
pembrolizumab
17
Specimen Handling
16
Platinum
14
1,2-diaminocyclohexaneplatinum II citrate
14
Paclitaxel
13
Cetuximab
13
Fluorouracil
10
Surgical Procedures, Operative
9
Docetaxel
9
Biopsy
9
Taxes
8
Chemoradiotherapy
8
Nivolumab
7
Fluorodeoxyglucose F18
7
Drug Therapy
7
durvalumab
6
Surveys and Questionnaires
6
fludarabine
5
X-Rays
5
Observation
5
Cyclophosphamide
5
aldesleukin
4
Standard of Care
4
Radiosurgery
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Oropharyngeal Neoplasms
×
Nimorazole
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled